Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Aug 22, 2024

BUY
$692.45 - $844.37 $449,400 - $547,996
649 New
649 $534,000
Q3 2023

Nov 09, 2023

BUY
$692.45 - $844.37 $10,386 - $12,665
15 Added 2.37%
649 $534,000
Q2 2023

Aug 09, 2023

BUY
$700.03 - $830.35 $443,819 - $526,441
634 New
634 $455,000
Q4 2022

Feb 08, 2023

SELL
$705.89 - $766.39 $982,598 - $1.07 Million
-1,392 Reduced 62.2%
846 $610,000
Q3 2022

Nov 03, 2022

SELL
$573.97 - $724.32 $1.15 Million - $1.45 Million
-2,008 Reduced 47.29%
2,238 $1.54 Million
Q2 2022

Aug 10, 2022

SELL
$548.35 - $738.84 $53,189 - $71,667
-97 Reduced 2.23%
4,246 $2.51 Million
Q1 2022

May 09, 2022

SELL
$595.12 - $698.43 $158,897 - $186,480
-267 Reduced 5.79%
4,343 $3.03 Million
Q4 2021

Feb 08, 2022

SELL
$543.48 - $670.97 $414,131 - $511,279
-762 Reduced 14.18%
4,610 $2.91 Million
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $85,530 - $101,463
149 Added 2.85%
5,372 $3.25 Million
Q2 2021

Aug 11, 2021

BUY
$472.8 - $558.54 $474,691 - $560,774
1,004 Added 23.8%
5,223 $3.26 Million
Q1 2021

May 11, 2021

BUY
$446.73 - $548.2 $116,149 - $142,532
260 Added 6.57%
4,219 $2 Million
Q4 2020

Feb 09, 2021

BUY
$478.3 - $607.98 $1.43 Million - $1.82 Million
2,994 Added 310.26%
3,959 $1.91 Million
Q3 2020

Nov 12, 2020

SELL
$544.75 - $658.21 $51,751 - $62,529
-95 Reduced 8.96%
965 $541,000
Q2 2020

Aug 07, 2020

BUY
$493.32 - $643.92 $522,919 - $682,555
1,060 New
1,060 $660,000
Q4 2018

Feb 12, 2019

SELL
$335.82 - $403.04 $1.37 Million - $1.65 Million
-4,089 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$351.14 - $408.51 $106,746 - $124,187
304 Added 8.03%
4,089 $1.65 Million
Q2 2018

Aug 02, 2018

SELL
$284.6 - $344.99 $68,019 - $82,452
-239 Reduced 5.94%
3,785 $1.31 Million
Q1 2018

May 11, 2018

SELL
$315.82 - $393.78 $5,053 - $6,300
-16 Reduced 0.4%
4,024 $1.39 Million
Q4 2017

Feb 09, 2018

SELL
$358.63 - $469.95 $85,353 - $111,848
-238 Reduced 5.56%
4,040 $1.52 Million
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $1.85 Million - $2.16 Million
4,278
4,278 $1.91 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $78.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Fiera Capital Corp Portfolio

Follow Fiera Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.